首页 > 市场调查报告书 > 医疗设备

体外诊断

市场调查报告书

商品编码

1563387

药物筛检市场规模、份额、成长分析、按产品和服务、按样本类型、按药物类型、按最终用户、按地区 - 行业预测，2024-2031 年

Drug Screening Market Size, Share, Growth Analysis, By Product & Service, By Sample Type, By Drug Type, By End User, By Region - Industry Forecast 2024-2031

出版日期: 2024年09月26日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球药物筛检市场规模为89亿美元，从2023年的103.7亿美元成长到2031年的351.8亿美元，预计复合年增长率为16.5%。

全球药物筛检市场在医疗保健领域迅速扩张，重点是个别药物及其代谢物的检测。这个市场在职场、医院、体育组织和执法部门等各种环境中都至关重要，有助于识别使用非法物质和滥用处方药的人。有几个因素推动药物筛检市场的成长。一个主要因素是药物滥用和成瘾现像日益普遍，增加了对有效筛检技术的需求。随着世界各国政府和组织越来越认识到药物滥用的社会和经济影响，强制进行药物检测的法规和政策变得越来越严格。此外，随着对职场安全的日益重视，许多公司正在实施无毒品政策，以提高员工生产力、减少工作场所事故并限制法律风险。此外，药物筛检技术的进步以及各领域对高可靠检测方法的需求也支持了市场的扩张。由于这些因素和不断变化的法规，药物筛检的重要性不断增加，预计未来几年将进一步成长，持续的技术创新将塑造市场的未来。

市场概况
药物筛检服务
- 实验室测试服务
- 现场测试服务
药物筛检产品
- 分析设备
- 按类型
- 酒精检测仪
- 燃料电池酒精检测仪
- 半导体酒精检测仪
- 其他酒精检测仪
- 免疫检测分析仪
- 层析法设备
- 按方式
- 手持式药物筛检产品
- 桌上型药物筛检产品
- 快速检测装置
- 尿液检查装置
- 药物测试杯
- 浸卡
- 药物测试盒
- 口腔液检测装置
- 消耗品
- 检测试剂套件
- 样本采集装置
- 校准器和控制装置
- 其他消耗品

药物筛检市场：依样本类型

市场概况
尿液样本
呼吸样本
口腔液样本
头髮样本
其他样品

药物筛检市场：依药物类型

市场概况
大麻
酒精
古柯碱
阿片类药物
安非他命和甲基安非他命
其他药品

药物筛检市场：依最终用户分类

市场概况
药物检测实验室
工作场所
刑事司法系统与执法
医院
戒毒治疗中心
个人用户
疼痛管理中心
学校和大学
其他最终用户

药物筛检市场规模：依地区划分

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Quest Diagnostics（US）
Abbott（US）
OraSure Technologies Inc.（US）
Alfa Scientific Designs Inc.（US）
Thermo Fisher Scientific Inc.（US）
Dragerwerk AG & Co. KGaA（Germany）
Lifeloc Technologies, Inc.（US）
MPD Inc.（US）
Omega Laboratories, Inc.（US）
Premier Biotech, Inc.（US）
Psychemedics Corporation（US）
F. Hoffmann-La Roche Ltd.（Switzerland）
Shimadzu Corporation（Japan）
Siemens Healthineers AG（Germany）
American Bio Medica Corporation（US）
ACM Global Laboratories（US）
CareHealth America Corp.（US）
Clinical Reference Laboratory, Inc.（US）
Intoximeters（US）
Sciteck, Inc.（US）
AccuSourceHR, Inc.（US）
Cordant Health Solutions（US）
Intoxalock（US）
Millennium Health（US）
AdvaCare Pharma（US）

简介目录

Product Code: SQMIG35D2198

Global Drug Screening Market size was valued at USD 8.9 billion in 2022 and is poised to grow from USD 10.37 billion in 2023 to USD 35.18 billion by 2031, growing at a CAGR of 16.5% during the forecast period (2024-2031).

The global drug screening market is expanding rapidly within the healthcare sector, focusing on detecting drugs or their metabolites in individuals. This market is essential across multiple environments, including workplaces, hospitals, sports organizations, and law enforcement agencies, where it helps identify those using illegal substances or misusing prescription drugs. Several factors are fueling the growth of the drug screening market. A major driver is the increasing prevalence of drug abuse and addiction, which has heightened the demand for effective screening techniques. Governments and organizations worldwide are becoming more aware of the social and economic impacts of drug abuse, leading to stricter regulations and policies that mandate drug testing. Additionally, there is a growing emphasis on workplace safety, with many companies implementing drug-free policies to enhance employee productivity, reduce workplace accidents, and limit legal risks. The market's expansion is also supported by advancements in drug screening technology and the need for reliable testing methods in various sectors. As the importance of drug screening continues to rise, driven by these factors and evolving regulations, the market is expected to grow further in the coming years, with ongoing innovations shaping its future.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Drug Screening market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Drug Screening Market Segmental Analysis

Global Drug Screening Market is segmented by Product & Service, Sample Type, application, end user and region. Based on Product & Service, the market is segmented into Drug Screening Services, and Drug Screening Products. Based on Sample Type, the market is segmented into Urine Samples, Breath Samples, Oral Fluid Samples, Hair Samples, and Other Samples. Based on Drug Type, the market is segmented into Cannabis, Alcohol, Cocaine, Opioids, Amphetamine and Methamphetamine, and Other Drugs. Based on end user, the market is segmented into Drug Testing Laboratories, Workplaces, Criminal Justice Systems and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual Users, Pain Management Centers, Schools and Colleges, and Other End Users. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global Drug Screening Market

The growing use of drug screening products and services on the road is expected to drive the overall expansion of the market, particularly as the prevalence of illicit drug use increases. Additionally, rising drug use among teenagers is likely to further boost market growth. The ease of implementing drug screening and its effectiveness in workplace testing are also contributing factors to this market expansion. However, the increase in government spending to combat drug trafficking may moderate the market's growth. Despite this, the market is anticipated to benefit from the rising incidence of traffic accidents related to drugged driving and prescription medication abuse, which will further accelerate its growth in the future.

Restraints in the Global Drug Screening Market

In certain environments, particularly workplaces, drug testing is perceived as an invasion of employee privacy, which is likely to hinder market growth. These privacy concerns may lead to resistance and slow the expansion of the drug screening market. Additionally, the industry faces potential challenges from regional restrictions on drug use and issues with the accuracy of breathalyzers. These factors could further impact the growth and adoption of drug screening solutions in various settings.

Market Trends of the Global Drug Screening Market

The global drug screening market is evolving with several prominent trends shaping its development. One major trend is the increasing adoption of advanced technologies, such as liquid chromatography-mass spectrometry (LC-MS) and immunoassays. These innovations are improving the sensitivity and accuracy of drug testing methods, enhancing the overall effectiveness of screening procedures. Another notable trend is the rising emphasis on oral fluid drug testing. Saliva-based tests offer a non-invasive and convenient alternative to traditional urine and blood tests. Although they have a shorter detection window, oral fluid tests provide real-time detection of drug use, making them particularly useful for post-accident and roadside testing. The market is also seeing growth in rapid on-site testing, expanded drug panels, and the integration of artificial intelligence (AI) and machine learning (ML). These advancements are aimed at increasing the accuracy, convenience, and efficiency of drug screening processes.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Trade Analysis
Supply chain Analysis
Case study Analysis
Patent Analysis
Customer & Buying Criteria Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Drug Screening Market by Product & Service

Market Overview
Drug Screening Services
- Laboratory Testing Services
- On-site Testing Services
Drug Screening Products
- Analytical Instruments
- By Type
- Breathalyzers
- Fuel-cell Breathalyzers
- Semiconductor Breathalyzers
- Other Breathalyzers
- Immunoassay analyzers
- Chromatography instruments
- By Modality
- Hand-held drug screening products
- Benchtop drug screening products
- Rapid Testing Devices
- Urine testing devices
- Drug testing cups
- Dip cards
- Drug testing cassettes
- Oral fluid testing devices
- Consumables
- Assay kits
- Sample collection devices
- Calibrators and controls
- Other consumables

Drug Screening Market by Sample Type

Market Overview
Urine Samples
Breath Samples
Oral Fluid Samples
Hair Samples
Other Samples

Drug Screening Market by Drug Type

Market Overview
Cannabis
Alcohol
Cocaine
Opioids
Amphetamine And Methamphetamine
Other Drugs

Drug Screening Market by End User

Market Overview
Drug Testing Laboratories
Workplaces
Criminal Justice Systems and Law Enforcement Agencies
Hospitals
Drug Treatment Centers
Individual Users
Pain Management Centers
Schools And Colleges
Other End Users

Drug Screening Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Quest Diagnostics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
OraSure Technologies Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alfa Scientific Designs Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Dragerwerk AG & Co. KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Lifeloc Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MPD Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Omega Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Premier Biotech, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Psychemedics Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Shimadzu Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Siemens Healthineers AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
American Bio Medica Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
ACM Global Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CareHealth America Corp. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Clinical Reference Laboratory, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intoximeters (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sciteck, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AccuSourceHR, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cordant Health Solutions (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intoxalock (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Millennium Health (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AdvaCare Pharma (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments